UBS Opportunistic Equity Income (S:0P0001JFEZ)
17.62
+0.62
(+3.65%)
USD |
Sep 30 2025
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Annual Total Returns Versus Peers
As of January 12, 2026.
*Indicates data for the year is incomplete.
Asset Allocation
| Type | % Net |
|---|---|
| Cash | -- |
| Stock | -- |
| Bond | -- |
| Convertible | -- |
| Preferred | -- |
| Other | -- |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| JPMorgan Chase & Co. | 6.28% | 323.20 | -1.82% |
| Alphabet, Inc. | 4.82% | 329.70 | 0.34% |
| Walmart, Inc. | 4.64% | 118.44 | 3.41% |
| Johnson & Johnson | 4.50% | 208.01 | 1.77% |
| RTX Corp. | 4.33% | 191.30 | 1.49% |
| Johnson Controls International Plc | 3.64% | 110.64 | -0.18% |
| The Goldman Sachs Group, Inc. | 3.46% | 940.96 | 0.21% |
| AstraZeneca PLC | 3.44% | 95.05 | 0.42% |
| Wells Fargo & Co. | 3.43% | 94.33 | -1.69% |
| AbbVie, Inc. | 3.39% | 219.21 | -0.40% |
Fees & Availability
| Fees | |
| Negotiable Fee | -- |
| Maximum Management Fee | -- |
| Prospectus Custodian Fee | -- |
| Purchase Details | |
| Open to New Investors | -- |
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Fundamentals
| General | |
| Number of Holdings | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| Number of Equity Holdings | -- |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Attributes | |
| Socially Responsible Fund | -- |